Health
Inhaled steroids reduce SARS-CoV-2-related genes in COPD – News-Medical.Net
A new study published on the preprint server medRxiv* aims to explore the effects of treatment with ICS on the expression of specific genes related to SARS-CoV-2 infection in bronchial epithelial cells in a prospective interventional design.
The chronic lung condition called COPD (chronic obstructive pulmonary disease) increases the risk of severe COVID-19.
Inhaled corticosteroids (ICS) are commonly prescribed to stabilize respiratory function in these patients, but the associated risk of bacterial infection has daunted some healthcare professionals from using them. Moreover, in vitro, studies show that they have an immunosuppressive effect on cells exposed to viruses. There is no evidence to reveal the effects of ICS on either sus…
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
General21 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
General13 hours agoPope Francis makes surprise first appearance after hospital stay
-
General20 hours agoDonald Trump and the ghost of Al Capone • Inside Story